Ken Griffin acquired 7.6 Thousand Supernus Pharmaceuticals shares worth $256 Thousand. That's 0.00% of their equity portfolio (3960th largest holding). The first Supernus Pharmaceuticals trade was made in Q2 2013. Since then Ken Griffin bought shares 50 more times and sold shares on 45 occasions. The stake costed the investor $256 Thousand, netting the investor a gain of 0.1% so far.